In Focus
Publication In Focus: CHRYSALIS study
NSCLC is the most common type of lung cancer. Mutations in the EGFR gene have been identified as being one of the most common causes of NSCLC. Patients with this type of mutation are ...
Read moreIn Focus: Minimal Residual Disease in multiple myeloma
FEATURES MRD negativity as a goal of therapy for multiple myeloma: an interview with Rafael Alonso Dr Rafael Alonso (Hospital Universitario 12 de Octubre, Madrid, Spain) discusses MRD ...
Read morePublication In Focus: TALAPRO-2
PARP inhibitors in combination with androgen receptor-targeted therapy have demonstrated potential in the treatment of metastatic castration-resistant prostate cancer (mCRPC). A recent ...
Read morePublication In Focus: Prognostication in skin cancer
Predicting the outcomes of skin cancer remains challenging, despite the advancement of tools that are available in the clinic. There is now a growing number of studies investigating the ...
Read morePublication In Focus: Using 40-GEP for enhanced metastatic risk assessment in cutaneous squamous cell carcinoma
Clinicians use clinicopathologic factors to determine risk for cutaneous squamous cell carcinoma (cSCC) disease progression. However, traditional methods miss pinpointing many patients ...
Read morePublication In Focus: INSIGHT 2
The INSIGHT 2 study (NCT03940703) is an international, open-label, multicenter, Phase II trial investigating the combination of tepotinib plus osimertinib in MET-amplified ...
Read moreIn Focus: recent therapies for breast cancer
In our latest In Focus we are shining a light on treatment options for subtypes of breast cancer through an infographic, panel discussion and news articles. Check out the infographic to ...
Read moreIn Focus: recent therapies for thyroid cancer
In our latest In Focus, Kate Newbold (Royal Marsden Hospital in London, UK) discusses treatment options for thyroid cancer and their limitations. Newbold also explores how we can ...
Read moreIn Focus: recent therapies in renal cell carcinoma
In our latest In Focus, Prof Brian Rini (Vanderbilt-Ingram Cancer Center, TN, USA) discusses the treatment landscape for people living with renal cell carcinoma (RCC), as well as the ...
Read morePublication In Focus: GioTag
The GioTag study investigated TKI sequencing in real-world patients with EGFR mutation-positive non-small-cell lung cancer (NSCLC) who develop T790M. The final data confirmed those of ...
Read morePublication In Focus: INSIGHT MM
With the introduction of new drugs with different mechanisms of action, multiple myeloma (MM) patients’ outcomes have improved. However, the efficacy seen in clinical trials is often ...
Read moreIn Focus: comprehensive genomic profiling
Comprehensive Genomic Profiling (CGP) utilizes next-generation sequencing technology to enable simultaneous detection of multiple cancer biomarkers. Currently, many sequential tests ...
Read moreIn Focus: coronavirus
Discover the latest oncology updates on the ongoing novel coronavirus outbreak. The COVID-19 outbreak has rapidly swept the world since first being reported in December 2019, leading to ...
Read moreIn Focus: World Cancer Day
World Cancer Day is an initiative by the Union of International Cancer Control that aims to unite the cancer community and increase awareness of what we can do to prevent and fight ...
Read moreIn Focus: CAR-T therapy
Traditionally, the foundation pillars of cancer treatment were surgery, radiotherapy and chemotherapy. However, with the advent of immuno-oncology – treatment modalities that utilize ...
Read moreIn Focus: lung cancer
Over the past years, there have been great advancements in the field of lung cancer; with the success we have seen with immunotherapy drugs such as Keytruda for non-small cell lung ...
Read moreIn Focus: hematologic malignancies
Numerous advancements have been made in treatment options for hematologic malignancies, with a big emphasis on precision medicine. As the field moves forwards with a stronger focus on ...
Read moreIn Focus: colorectal cancer
The world’s third most common cancer, colorectal cancer is responsible for an estimated 694,000 annual deaths worldwide. The few last decades have brought great improvements in survival ...
Read moreIn Focus: skin cancer
Over the past few years, advances in the treatment of skin cancers have improved both overall and progression free survival for patients. However, the sudden and increasing array of ...
Read moreIn Focus: breast cancer
The roll out of more effective and affordable screening programes alongside advancements in treatment options have resulted in declining death rates over the last few decades. Despite ...
Read moreIn Focus: cervical cancer
To mark Cervical Cancer Awareness Week we have collated our most-popular cervical cancer content. Highlights include breaking news, peer-reviewed research and opinion pieces from key ...
Read more